aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
SpIntellx, founded with a mission to revolutionize personalized medicine, leverages advanced AI and spatial analytics to enhance patient outcomes. The company focuses on developing AI-powered software that utilizes spatial systems pathology and explainable artificial intelligence (xAI) to analyze pathology samples. This technology aims to create predictive insights necessary for personalized treatment plans, particularly in the field of immunotherapy for cancer patients.
Notable figures associated with SpIntellx include leading experts in computational biology and AI. The company has attracted significant investment from prominent venture capital firms specializing in healthcare innovation. Key achievements include the development of their Spatially Intelligent Platform, which has shown promise in bending the survival curve for cancer patients undergoing immunotherapy. SpIntellx's impact is marked by its potential to transform how personalized medicine is approached, offering more precise and effective treatment options.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Software, Analytics
Technology
AI, Machine Learning
Tags
Biotech, Ai Operations
Model Types
SaaS
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise, Healthcare
Geographic Exposure
Americas
When was SpIntellx founded?
SpIntellx was founded in 2017.
Where is SpIntellx's headquarters located?
SpIntellx's headquarters is located in Pittsburgh, PA, US.
How many employees does SpIntellx have?
SpIntellx has 5 employees as of Feb 4, 2024.
How much has SpIntellx raised to-date?
As of July 05, 2023, SpIntellx has raised a total of $1.7M (USD) since Feb 28, 2023.
Add Comparison
Total Raised to Date
$1.7M
USD
Last Update Feb 28, 2023
Total Employees Over Time
5
As of Feb 2024
SpIntellx Address
2425 Sidney St
Pittsburgh,
Pennsylvania
15203
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts